Portugal · pharmaceuticals
Portugal · pharmaceuticalsSOMAÍ Pharmaceuticals
A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint
PrivateFor profit
Against its peers
Set against 666 pharmaceuticals companies worldwide. The ring marks the typical peer.
Across all 5.9M companies: larger than 85% of those with a size listed; older than 5% of those with a founding year; website ranked #6,801,245 in the world, about 1k visits a month.
About SOMAÍ Pharmaceuticals
BiopharmaBiotechnologyCannabisPharmaceutical
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$38M
raised in total, currency not stated across 5 rounds
Last raised Jul 2024, 2 years ago
- Rounds
- 5
- Latest round
- Series b
- Investors
- 1
Key facts
Who started it and how it trades.
- Founded by
- George Bellow, Michael Sassano
Every detail we hold
Everything the source datasets list about SOMAÍ Pharmaceuticals, field by field. Contact details are held but never shown.
The company7 fields
- Name
- SOMAÍ Pharmaceuticals
- Type
- For profit
- Status
- Private
- Founded
- 2019
- Founders
- George Bellow, Michael Sassano
- Industry
- pharmaceuticals
- Categories
- Biopharma, Biotechnology, Cannabis, Pharmaceutical
Where3 fields
- City
- Lisbon
- Country
- Portugal
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach3 fields
- Staff band
- 101-250
- Web traffic rank
- #6,801,245
- Monthly web visits
- 1,014
Show 8 more fieldsShow fewer fields
Funding, as listed6 fields
- Total
- 37,700,000 (currency not stated)
- Rounds
- 5
- Latest round
- Series b
- Latest round date
- Jul 2024
- Investors
- 1
- Listing status
- private
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
SOMAÍ Pharmaceuticals may be growing due to the recent legislative changes in Germany, where the parliament has voted to legalize limited adult-use cannabis. This development could potentially expand the market for the company's cannabinoid-containing pharmaceutical medicines. As a pharmaceutical and biotech company operating in the cannabis industry, such regulatory advancements are likely to have a positive impact on SOMAÍ Pharmaceuticals' business environment, potentially increasing demand for their products.
Companies like SOMAÍ Pharmaceuticals
pharmaceuticals in Portugal.
Build a lead list
Every pharmaceuticals company, filtered by size, age and reach, ready to export with emails on Pro.